US Stock MarketDetailed Quotes

ACHL Achilles Therapeutics

Watchlist
  • 1.075
  • +0.005+0.47%
Close Nov 29 13:00 ET
  • 1.070
  • -0.005-0.47%
Post 17:01 ET
44.17MMarket Cap-647P/E (TTM)

About Achilles Therapeutics Company

Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.

Company Profile

SymbolACHL
Company NameAchilles Therapeutics
Listing DateMar 31, 2021
Issue Price18.00
Founded2020
CEODr. Iraj Ali, PhD
MarketNASDAQ
Employees215
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address245 Hammersmith Road
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW6 8PW
Phone44-20-8154-4600
Websitehttp://achillestx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Iraj Ali, PhD
  • Chief Executive Officer and Director
  • 1.70M
  • Dr. Karl Peggs, M.D.
  • Chief Medical Officer
  • --
  • Robert Coutts
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Sergio Quezada, PhD
  • Chief Scientific Officer
  • --
  • Dr. Edwin Moses, B.Sc. ,PhD
  • Chairman of the Board
  • 379.00K
  • Dr. Bernhard R.M. Ehmer
  • Independent Director
  • 106.00K
  • Dr. Michael F. Giordano, M.D.
  • Independent Director
  • 189.00K
  • Julie ONeill
  • Independent Director
  • 102.00K
  • Carsten Boess
  • Independent Director
  • 176.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data